Common Contracts

First Amendment to Commercialization Agreement

Commercialization Agreement • June 11th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories

• Contract Type
  Commercialization Agreement
• Filed
  June 11th, 2021
• Company
  Sera Prognostics, Inc.
• Industry
  Services-medical laboratories

This First Amendment to Commercialization Agreement (“Amendment”) is made and shall be effective upon the date this Amendment is signed by both Parties (“Amendment Date”) by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”

First Amendment to Commercialization Agreement

Commercialization Agreement • May 5th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories

• Contract Type
  Commercialization Agreement
• Filed
  May 5th, 2021
• Company
  Sera Prognostics, Inc.
• Industry
  Services-medical laboratories

This First Amendment to Commercialization Agreement (“Amendment”) is made and shall be effective upon the date this Amendment is signed by both Parties (“Amendment Date”) by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”

First Amendment to Commercialization Agreement

Commercialization Agreement • March 29th, 2021 • Sera Prognostics, Inc. • Services-medical laboratories

• Contract Type
  Commercialization Agreement
• Filed
  March 29th, 2021
• Company
  Sera Prognostics, Inc.
• Industry
  Services-medical laboratories

This First Amendment to Commercialization Agreement (“Amendment”) is made and shall be effective upon the date this Amendment is signed by both Parties (“Amendment Date”) by and between Sera Prognostics, Inc. (“Sera”), a Delaware corporation with its principal place of business at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah 84109, and Laboratory Corporation of America Holdings (“LabCorp”), a Delaware corporation with its principal place of business at 531 South Spring Street, Burlington, North Carolina 27215. Each of Sera and LabCorp is referred to herein as a “Party” and together as the “Parties.”